Kinevant Sciences GmbH

Clinical research is centered on chronic pulmonary sarcoidosis, with a focus on inflammatory disease affecting the lungs and the clinical burden of worsening respiratory symptoms.

• Chronic pulmonary sarcoidosis
• Lung inflammatory disease
• Respiratory inflammation

The sponsor’s research interest lies in therapies aimed at controlling pulmonary inflammation and reducing the need for rescue treatment in patients with active disease.